# R-Lipoic Acid (R-Alpha Lipoic Acid)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/r-lipoic-acid
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-29
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** R-Alpha Lipoic Acid, R-ALA, R-(+)-Alpha Lipoic Acid, (R)-Alpha Lipoic Acid, R-Thioctic Acid, Natural Alpha Lipoic Acid, Bio-Enhanced R-Lipoic Acid, (5R)-(+)-1,2-dithiolane-3-pentanoic acid

## Overview

R-lipoic acid (R-ALA) is the biologically native enantiomer of alpha-lipoic acid, acting as an essential cofactor for [mitochondrial](/ingredients/condition/energy) enzyme complexes including pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase. It exerts [antioxidant](/ingredients/condition/antioxidant) effects in both its oxidized (R-LA) and reduced (R-DHLA) forms, with superior bioavailability compared to the synthetic S-enantiomer.

## Health Benefits

• Limited clinical evidence available - the research dossier lacks specific human clinical trial data for R-lipoic acid
• Functions as a cofactor in mitochondrial [energy metabolism](/ingredients/condition/energy) enzyme complexes
• Contributes to [antioxidant activity](/ingredients/condition/antioxidant) through its oxidized and reduced forms
• May support metabolic processes as the preferred nutritional eutomer over S-lipoic acid
• General lipoic acid (racemic form) has been studied since the 1950s-1960s in Europe and Japan, but R-lipoic acid specific efficacy data is limited

## Mechanism of Action

R-lipoic acid functions as a covalently bound cofactor for [mitochondrial](/ingredients/condition/energy) 2-oxoacid dehydrogenase complexes, facilitating acyl-group transfer during oxidative decarboxylation of pyruvate and alpha-ketoglutarate. Its reduced form, R-dihydrolipoic acid (R-DHLA), directly scavenges [reactive oxygen species](/ingredients/condition/antioxidant) and regenerates endogenous antioxidants including [glutathione](/ingredients/condition/detox), vitamin C, and vitamin E by reducing their oxidized counterparts. R-ALA also activates Nrf2 transcription factor signaling, upregulating endogenous antioxidant enzyme expression including superoxide dismutase and glutathione peroxidase.

## Clinical Summary

Most published human clinical trials have used racemic ALA (50% R-, 50% S-enantiomer) rather than isolated R-lipoic acid, limiting direct evidence for R-ALA alone. Racemic ALA trials at 600–1800 mg/day have demonstrated reductions in neuropathic pain scores in diabetic peripheral neuropathy across multiple randomized controlled trials including the ALADIN and SYDNEY trials involving 300–500 participants. Pharmacokinetic studies confirm R-ALA achieves approximately 40–50% higher plasma peak concentrations than S-ALA when administered as the isolated enantiomer, suggesting greater biological activity per milligram. Head-to-head human trials comparing R-ALA to racemic ALA for clinical outcomes remain sparse, and robust standalone R-ALA trial data are currently insufficient to draw definitive efficacy conclusions.

## Nutritional Profile

R-Lipoic Acid (R-ALA) is a pure enantiomer of alpha-lipoic acid, not a macronutrient source. It contains no protein, fat, carbohydrate, fiber, vitamins, or minerals in meaningful quantities. As a bioactive compound, it is typically supplied in supplemental doses of 50–300 mg per serving. The R-enantiomer is the naturally occurring, biologically active form synthesized endogenously in mitochondria and found in trace amounts in food sources such as spinach (~3–5 mg/kg), broccoli (~3–4 mg/kg), and organ meats such as heart and kidney (~1–3 mg/kg), where it exists protein-bound. As a free (unbound) supplement, R-ALA is highly bioavailable, with plasma peak concentrations reached within 30–60 minutes of oral ingestion; free R-ALA exhibits approximately 40–50% greater bioavailability compared to the racemic (R/S) mixture due to absence of competitive absorption with the S-enantiomer. It functions as a dithiol redox-active compound cycling between its oxidized disulfide form (R-lipoic acid) and reduced dithiol form (R-dihydrolipoic acid, R-DHLA). R-DHLA has a reduction potential of approximately −0.32 V, enabling regeneration of [antioxidant](/ingredients/condition/antioxidant)s including [glutathione](/ingredients/condition/detox), vitamin C, and vitamin E. As a cofactor, it is covalently bound to the E2 subunits of pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase complexes. Endogenous synthesis is limited and declines with age. Stability note: free R-ALA is less thermally stable than the racemic form and may polymerize at elevated temperatures; stabilized salt forms (e.g., sodium R-lipoate) improve shelf stability and dissolution rate.

## Dosage & Preparation

No clinically studied dosage ranges, forms, or standardization details are provided in the available research for R-lipoic acid. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

R-lipoic acid is generally well tolerated at doses of 100–600 mg/day, with the most commonly reported adverse effects being nausea, vomiting, and gastrointestinal upset, particularly when taken on an empty stomach. It may enhance [insulin sensitivity](/ingredients/condition/weight-management) and lower blood glucose, creating an additive hypoglycemic risk when combined with insulin, metformin, or sulfonylurea medications, requiring blood glucose monitoring. R-ALA can chelate divalent minerals including iron, zinc, and magnesium, potentially reducing their absorption if taken simultaneously. Safety in pregnancy and lactation has not been established in controlled human studies, and use during these periods is not recommended without medical supervision.

## Scientific Research

The research dossier indicates that search results lack specific details on key human clinical trials, RCTs, or meta-analyses for R-lipoic acid, including PubMed PMIDs. While general lipoic acid (often racemic R/S form) has been studied clinically in Europe and Japan since the 1950s-1960s, R-lipoic acid-specific bioequivalence and efficacy data are limited.

## Historical & Cultural Context

No evidence of historical or traditional medicinal use in any systems (such as Ayurveda or TCM) is mentioned in the research. Lipoic acid's clinical exploration began with synthetic racemic forms in Europe and Japan in the 1950s-1960s.

## Synergistic Combinations

Information not available in research dossier

## Frequently Asked Questions

### What is the difference between R-lipoic acid and alpha-lipoic acid?

Alpha-lipoic acid sold in most supplements is a racemic mixture containing equal amounts of the R- and S-enantiomers, while R-lipoic acid is the isolated form that occurs naturally in the body. The R-enantiomer is the biologically active form that binds mitochondrial enzyme complexes, and pharmacokinetic data show it achieves roughly 40–50% higher peak plasma concentrations than the S-form, meaning lower doses may produce equivalent physiological effects.

### What is the recommended dosage of R-lipoic acid?

Because R-ALA has higher bioavailability than racemic ALA, typical supplemental doses range from 100–300 mg/day for R-ALA compared to the 300–600 mg/day commonly used for racemic ALA. Most manufacturers recommend taking it on an empty stomach to maximize absorption, as food has been shown to reduce peak plasma concentrations by approximately 30%. No universally established therapeutic dose exists for R-ALA alone due to limited standalone clinical trial data.

### Can R-lipoic acid help with diabetic neuropathy?

The strongest clinical evidence for lipoic acid in diabetic neuropathy comes from trials using intravenous or oral racemic ALA, including the SYDNEY 2 trial which showed significant reductions in Total Symptom Score after 600 mg/day oral racemic ALA for 5 weeks in 181 patients. Isolated R-ALA has not been studied independently in large neuropathy trials, but its superior bioavailability suggests potential equivalence or superiority at lower doses. Direct evidence specifically for R-ALA in neuropathy requires further dedicated clinical investigation.

### Does R-lipoic acid interact with any medications?

R-lipoic acid has a clinically relevant interaction with antidiabetic medications including insulin, metformin, and sulfonylureas due to its insulin-sensitizing effects, which can cause additive blood glucose lowering and risk of hypoglycemia. It may also reduce the absorption of thyroid hormone medications such as levothyroxine if taken simultaneously, and should be separated by at least 2–4 hours. Additionally, its metal-chelating properties can interfere with iron and zinc supplementation absorption, so co-administration should be spaced apart.

### Is R-lipoic acid better absorbed than regular alpha-lipoic acid?

Yes, pharmacokinetic studies demonstrate that the R-enantiomer achieves significantly higher bioavailability than the S-enantiomer, with peak plasma concentrations approximately 40–50% greater for R-ALA when each is administered in pure form. The S-enantiomer found in racemic mixtures may actually compete with and partially inhibit R-ALA absorption and cellular uptake. Stabilized forms of R-ALA, such as sodium R-lipoate, are also used to address the compound's tendency to polymerize at elevated temperatures, which can further improve consistency of absorption.

### Why is R-lipoic acid considered the active form compared to S-lipoic acid?

R-lipoic acid is the naturally occurring eutomer that functions as a cofactor in critical mitochondrial enzyme complexes involved in energy metabolism, making it the biologically active form. S-lipoic acid, the mirror-image isomer, does not participate in these essential metabolic pathways and may compete with R-lipoic acid for absorption and utilization. This is why R-lipoic acid is often preferred as a standalone supplement for targeted metabolic support.

### What is the role of R-lipoic acid in mitochondrial function and energy production?

R-lipoic acid serves as a cofactor in mitochondrial enzyme complexes that are central to cellular energy (ATP) production and the citric acid cycle. As both an oxidized and reduced molecule, it participates in electron transfer reactions that are essential for efficient energy metabolism at the cellular level. This metabolic role underlies many of the health benefits attributed to R-lipoic acid supplementation.

### How does R-lipoic acid work as an antioxidant in the body?

R-lipoic acid functions as a dual-action antioxidant by existing in two forms—the oxidized form that can accept electrons and the reduced form (dihydrolipoic acid) that can donate electrons—allowing it to neutralize free radicals in multiple cellular compartments. It can regenerate other antioxidants such as vitamins C and E, amplifying overall antioxidant defense. This unique redox cycling capability makes R-lipoic acid effective in both water-soluble and fat-soluble environments within cells.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*